Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Triglyceride-Glucose Index (Tyg) As a Novel Biomarker in the Era of Cardiometabolic Medicine Publisher Pubmed

Summary: Study finds TyG index may predict diabetes and heart disease risk, aiding early prevention. #Cardiometabolic #HealthScreening

Avagimyan A1 ; Pogosova N2, 3 ; Fogacci F4 ; Aghajanova E5 ; Djndoyan Z6 ; Patoulias D7 ; Sasso LL8 ; Bernardi M9 ; Faggiano A10, 11 ; Mohammadifard N12 ; Neglia D13 ; Carugo S10, 11 ; Cicero A14, 15 ; Rizzo M16, 17 Show All Authors
Authors
  1. Avagimyan A1
  2. Pogosova N2, 3
  3. Fogacci F4
  4. Aghajanova E5
  5. Djndoyan Z6
  6. Patoulias D7
  7. Sasso LL8
  8. Bernardi M9
  9. Faggiano A10, 11
  10. Mohammadifard N12
  11. Neglia D13
  12. Carugo S10, 11
  13. Cicero A14, 15
  14. Rizzo M16, 17
  15. Biondizoccai G9, 18
  16. De Caterina R19
  17. Sarrafzadegan N20, 21

Source: International Journal of Cardiology Published:2025


Abstract

In the period of increasing prevalence of metabolic disorders such as obesity and diabetes, healthcare professionals are facing significant challenges. Therefore, an accurate global assessment of insulin resistance is of utmost importance. Current medical research is focused on identifying an easily accessible and reproducible gold-standard surrogate marker for insulin resistance. Ideally, such a marker would enable healthcare providers to predict the risk of type 2 diabetes and cardiovascular diseases. The triglyceride-glucose index (TyG) is a promising marker for preventive cardiology and cardiometabolic medicine. This narrative review article aims to provide a comprehensive evaluation of the credibility of TyG as a surrogate marker of insulin resistance among patients at different stages across the cardiometabolic continuum. This assessment fully complies with evidence-based medicine and offers valuable insight into the clinical utility of TyG. © 2024
Related Docs
View other Related Docs
1. The Product of Triglycerides and Glucose in Comparison With Fasting Plasma Glucose Did Not Improve Diabetes Prediction, Acta Diabetologica (2015)
2. Association of the Triglyceride Glucose Index As a Measure of Insulin Resistance With Mortality and Cardiovascular Disease in Populations From Five Continents (Pure Study): A Prospective Cohort Study, The Lancet Healthy Longevity (2023)
3. Association of Triglyceride Glucose Index With Cardiovascular Events: Insights From the Isfahan Cohort Study (Ics), European Journal of Medical Research (2024)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (7)
Masoumeh Sadeghi (6)
Triglyceride-Glucose Index (Tyg) As a Novel Biomarker in the Era of Cardiometabolic Medicine
Other Related Docs
4. Assessing the Predictive Value of Insulin Resistance Indices for Metabolic Syndrome Risk in Type 2 Diabetes Mellitus Patients, Scientific Reports (2024)
5. Comparison of Glycated Hemoglobin With Fasting Plasma Glucose in Definition of Glycemic Component of the Metabolic Syndrome in an Iranian Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2012)
6. Anthropometric Indices Predicting Incident Type 2 Diabetes in an Iranian Population: The Isfahan Cohort Study, Diabetes and Metabolism (2013)
7. Validity of Triglyceride–Glucose Index As an Indicator for Metabolic Syndrome in Children and Adolescents: The Caspian-V Study, Eating and Weight Disorders (2018)
8. Risk of Diabetes in Combined Metabolic Abnormalities and Body Mass Index Categories, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2016)
9. Lipid Accumulation Product and Visceral Adiposity Index for Incidence of Cardiovascular Diseases and Mortality; Results From 13 Years Follow-Up in Isfahan Cohort Study, Obesity Science and Practice (2024)
10. Glycated Hemoglobin As a Predictor for Metabolic Syndrome in an Iranian Population With Normal Glucose Tolerance, Metabolic Syndrome and Related Disorders (2012)
11. Accuracy of Novel Anthropometric Indices for Assessing the Risk for Progression of Prediabetes to Diabetes; 13 Years of Results From Isfahan Cohort Study, Archives of Endocrinology and Metabolism (2024)
12. Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Annals of Nutrition and Metabolism (2016)
13. Relationship Between Serum Resistin Concentrations With Metabolic Syndrome and Its Components in an Iranian Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2015)
14. Appropriate Cut-Off Values of Waist Circumference to Predict Cardiovascular Outcomes: 7-Year Follow-Up in an Iranian Population, Internal Medicine (2012)
15. Risk of Diabetes According to the Metabolic Health Status and Degree of Obesity, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2017)
16. Metabolic Syndrome in Iranian Patients With Systemic Lupus Erythematosus and Its Determinants, Clinical Rheumatology (2018)
17. Does the Impact of Metabolic Syndrome on Cardiovascular Events Vary by Using Different Definitions? Chronic Disease Epidemiology, BMC Public Health (2015)
18. Pre-Diabetes and Cardiovascular Risk Factors in Nafld Patients: A Retrospective Comparative Analysis, Frontiers in Endocrinology (2025)
19. Apopulation-Based Metabolic Syndrome Risk Score and Its Determinants: The Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2014)
20. A Systematic Review and Meta-Analysis of the Association Between Fish Consumption and Risk of Metabolic Syndrome, Nutrition, Metabolism and Cardiovascular Diseases (2020)